RAPP vs RLAY Stock Comparison

RLAY currently leads RAPP in this stock comparison, with AIQ scores of 56 vs 43. The clearest difference is momentum, while RAPP has the stronger quality profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 13 points
RAPP
Healthcare
vs
RLAY
Healthcare
RAPP
Rapport Therapeutics, Inc. Common Stock
Price
$26.15
Day move
+1.16%
AIQ Score
43/100
Best edge
Quality
Sector
Healthcare
RLAY
Relay Therapeutics, Inc.
Leads
Price
$18.09
Day move
+0.06%
AIQ Score
56/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between RAPP and RLAY?

RLAY leads the current stock comparison as Relay Therapeutics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Rapport Therapeutics, Inc. Common Stock vs Relay Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

RLAY leads

RLAY leads by 13 AIQ points, primarily on Momentum and Risk Resilience, and the lead has widened from 4 points over 30 sessions. Wall Street currently favors RAPP on target upside.

Competitive: 3 of 6 evidence groups support RLAY, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Strengthening
RAPP

Rapport Therapeutics, Inc. Common Stock

AIQ Score
43/100
AIQ Edge Score
3/10
RLAY

Relay Therapeutics, Inc.

Leads
AIQ Score
56/100
AIQ Edge Score
5/10

The Algovestiq AIQ Score currently favors RLAY over RAPP, 56 versus 43 as of Nov 15, 2026. RLAY's advantage is driven primarily by stronger momentum and risk resilience, while RAPP holds the stronger quality profile. RLAY also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors RAPP. 3 of 6 covered evidence groups favor RLAY today, and the comparison is rated Competitive on stability: only 3 of 6 covered evidence groups agree. RLAY lead: Strengthening — the AIQ differential moved from 4 to 13 points over 30 sessions.

Compare Rapport Therapeutics, Inc. Common Stock and Relay Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

RAPP
+25.7%
RLAY
+129.0%

Price return comparison

Growth of $10,000, price only

RAPP $12,572 · RLAY $22,899

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare RAPP and RLAY against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

RAPP advantage
0
RLAY advantage
  • Momentum33 vs 76
    RLAY +43
  • Risk Resilience39 vs 52
    RLAY +13
  • Quality57 vs 47
    RAPP +10
  • Value42 vs 37
    RAPP +5

3 of 6 evidence groups favor RLAY. RLAY’s edge is concentrated in momentum and risk resilience; RAPP keeps a meaningful quality edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

RAPP0 AIQ

Largest factor move: Value +1, not enough on its own to move the overall score.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-5.2%)
  • RSI Bullish Divergence — bullish, momentum, medium horizon
RLAY+1 AIQ

Largest factor move: Value +2

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.58x)

RLAY's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — RAPP and RLAY both carry a full feed there.

The central trade-off

RLAY (Relay Therapeutics, Inc.): the stronger current systematic profile, led by momentum and risk resilience.

RAPP (Rapport Therapeutics, Inc. Common Stock): the counter-case, on quality, value, fundamentals — but at materially higher volatility, 111.1% against 80.3%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

RLAY

RLAY on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

RAPP

RAPP on combined revenue and EPS growth.

Value

RAPP

RAPP on the peer-relative Value factor, by 5 points.

Momentum

RLAY

RLAY on the Momentum factor, by 43 points.

Lower downside

RLAY

RLAY on Risk Resilience, by 13 points.

Analyst upside

RAPP

RAPP on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors RLAY, analyst targets favor RAPP. That disagreement is the most useful thing on this page.

MeasureRAPPRLAYNote
Implied upside to target+173.9%+60.3%RAPP has more room
Target dispersion+61.4%0%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1613Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor RLAY. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreRLAY43 vs 56
FundamentalsRAPPEPS growth 29.4% vs 9.8%; TTM ROE -10.3% vs -10%; gross margin 100% vs 89.3%; operating margin -8.4% vs -30.9%
ValuationRAPPValue 42 vs 37
TechnicalsRLAYPrice vs 50-day -18.1% vs -1.5%; vs 200-day -26.5% vs 16.4%
Risk ResilienceRLAYRisk Resilience 39 vs 52
Analyst expectationsRAPPTarget upside 173.9% vs 60.3%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of RAPP and RLAY and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 13 points. (supports the conclusion holding)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on RLAY.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

RLAY lead: Strengthening — the AIQ differential moved from 4 to 13 points over 30 sessions.

May 27RAPP leads above the line · RLAY leads belowNov 13
Today
RLAY +13
43 vs 56
7 sessions ago
RLAY +13
42 vs 55
30 sessions ago
RLAY +4
45 vs 49
90 sessions ago
RAPP +5
65 vs 60

The lead changed hands once in this window, most recently on Sep 30 when RLAY moved ahead of RAPP.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

RAPPConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only RAPP

  • Death Cross Active — bearish, trend, long horizon (11.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-5.2%)
  • RSI Bullish Divergence — bullish, momentum, medium horizon
RLAYConflicted

3 bullish / 2 bearish / 2 neutral, conflicted

Only RLAY

  • Golden Cross Active — bullish, trend, long horizon (18.25%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.58x)
  • TRIX Bullish Signal — bullish, momentum, short horizon

Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.

RLAY leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

RAPPNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.16%, AIQ 0 points).

RLAYNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.06%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1RAPP closes the Momentum gap — currently 43 points behind, the largest single contributor to RLAY's edge.
  2. 2RAPP's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3RLAY's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

RAPP leads on balance
MetricRAPPRLAY
Revenue growth (YoY)0%-100%
EPS growth (YoY)29.4%9.8%
Gross margin100%89.3%
Operating margin-8.4%-30.9%
Return on equity (TTM)-10.3%-10%
Debt to equity0.020.03

Performance

RLAY leads 5 of 6 windows
MetricRAPPRLAY
1 week (5 sessions)7%-2.7%
1 month (20 sessions)-5.2%11.1%
3 months (63 sessions)-46%-12.5%
6 months (126 sessions)-29.5%48.3%
Year to date-13.8%113.8%
1 year (252 sessions)3.9%193.2%

Technicals

RLAY has the stronger structure
MetricRAPPRLAY
RSI (14)44.947.9
ADX (14)31.414.3
Price vs 50-day-18.1%-1.5%
Price vs 200-day-26.5%16.4%
Volatility (1M, annualized)111.1%80.3%

Risk

RLAY is the more resilient
MetricRAPPRLAY
Beta1.271.66
Sharpe ratio0.351.84
Sortino ratio0.473.13
Max drawdown-57.1%-28.2%
Current drawdown-50.2%-12.8%
Annualized volatility62.3%65.8%
Value at risk (95%)-5.8%-5.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, RAPP or RLAY?

On the Algovestiq AIQ Score, RLAY is the stronger of the two as of Nov 15, 2026, scoring 56 against RAPP's 43. The edge comes from momentum and risk resilience. RAPP is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is RAPP or RLAY the better buy right now?

RLAY carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor RLAY over RAPP?

The composite weights Quality, Value, Momentum and Risk Resilience. RLAY leads Momentum by 43 points; RLAY leads Risk Resilience by 13 points; RAPP leads Quality by 10 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, RAPP or RLAY?

Analyst price targets imply +173.9% upside for RAPP and +60.3% for RLAY, so the Street currently favors RAPP. That points the opposite way to the AIQ Score, which favors RLAY. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, RAPP or RLAY?

RAPP is the better-valued of the two on the peer-relative Value factor. RAPP on the peer-relative Value factor, by 5 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, RAPP or RLAY?

RAPP on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, RAPP or RLAY?

RLAY on the Momentum factor, by 43 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, RAPP or RLAY?

RLAY is the more resilient of the two, so the other name carries the higher downside risk. RLAY on Risk Resilience, by 13 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is RAPP more profitable than RLAY?

RAPP leads on the comparable margin measures — gross margin 100% vs 89.3%; operating margin -8.4% vs -30.9%; ttm roe -10.3% vs -10%.

Is RLAY's lead over RAPP getting stronger or weaker?

RLAY lead: Strengthening — the AIQ differential moved from 4 to 13 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-09-30, when RLAY moved ahead of RAPP.

What would change the RAPP vs RLAY verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RAPP closes the Momentum gap — currently 43 points behind, the largest single contributor to RLAY's edge; RAPP's Death Cross Active resolves — a bearish trend rule currently active against it; RLAY's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about RAPP and RLAY?

RAPP: 2 bullish / 2 bearish / 1 neutral, conflicted. RLAY: 3 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on RAPP is Death Cross Active (bearish, long horizon). On RLAY it is Golden Cross Active (bullish, long horizon).

Compare RAPP and RLAY with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.